<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="editorial">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Psychiatry</journal-id>
<journal-title>Frontiers in Psychiatry</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Psychiatry</abbrev-journal-title>
<issn pub-type="epub">1664-0640</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fpsyt.2021.773034</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Psychiatry</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Neuroimaging Biomarkers in Mood and Anxiety Disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Lai</surname> <given-names>Chien-Han</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/55406/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Kim</surname> <given-names>Yong-Ku</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/460068/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Radua</surname> <given-names>Joaquim</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/21549/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Institute of Biophotonics, National Yang-Ming University</institution>, <addr-line>Taipei</addr-line>, <country>Taiwan</country></aff>
<aff id="aff2"><sup>2</sup><institution>PhD Psychiatry &#x00026; Neuroscience Clinic</institution>, <addr-line>Taoyuan City</addr-line>, <country>Taiwan</country></aff>
<aff id="aff3"><sup>3</sup><institution>Korea University</institution>, <addr-line>Seoul</addr-line>, <country>South Korea</country></aff>
<aff id="aff4"><sup>4</sup><institution>Imaging of Mood- and Anxiety-Related Disorders (IMARD) Group, Institut d&#x00027;Investigacions Biom&#x000E8;diques August Pi i Sunyer (IDIBAPS), Centro de Investigaci&#x000F3;n Biom&#x000E9;dica en Red de Salud Mental (CIBERSAM)</institution>, <addr-line>Barcelona</addr-line>, <country>Spain</country></aff>
<aff id="aff5"><sup>5</sup><institution>Institute of Psychiatry, Psychology, and Neuroscience, King&#x00027;s College London</institution>, <addr-line>London</addr-line>, <country>United Kingdom</country></aff>
<aff id="aff6"><sup>6</sup><institution>Department of Clinical Neuroscience, Karolinska Institute</institution>, <addr-line>Stockholm</addr-line>, <country>Sweden</country></aff>
<author-notes>

<fn fn-type="edited-by"><p>Edited and reviewed by: Drozdstoy Stoyanov Stoyanov, Plovdiv Medical University, Bulgaria</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Chien-Han Lai <email>stephenlai99&#x00040;gmail.com</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Mood Disorders, a section of the journal Frontiers in Psychiatry</p></fn></author-notes>
<pub-date pub-type="epub">
<day>29</day>
<month>10</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>12</volume>
<elocation-id>773034</elocation-id>
<history>
<date date-type="received">
<day>09</day>
<month>09</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>01</day>
<month>10</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2021 Lai, Kim and Radua.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Lai, Kim and Radua</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license> </permissions>
<related-article id="RA1" related-article-type="commentary-article" xlink:href="https://www.frontiersin.org/research-topics/14684/neuroimaging-biomarkers-in-mood-and-anxiety-disorders" ext-link-type="uri">Editorial on the Research Topic <article-title>Neuroimaging Biomarkers in Mood and Anxiety Disorders</article-title></related-article> 
<kwd-group>
<kwd>depression</kwd>
<kwd>anxiety</kwd>
<kwd>MRI</kwd>
<kwd>MEG</kwd>
<kwd>TMS</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="2"/>
<word-count count="1113"/>
</counts>
</article-meta>
</front>
<body>  
<p>For the coming new era of the modern world, accumulating stressors will represent a significant hurdle, likely increasing the prevalence of mood and anxiety disorders. Furthermore, the consequences of the COVID-19 pandemic may further increase these disorders. Thus, we need to investigate potential biomarkers for these disorders, as they could assist us in alleviating the clinical symptoms and preventing the subsequent sequela. Since we know that the brain controls and manipulates psychological status and related behaviors, we should scrutinize the brain&#x00027;s biomarkers of mood and anxiety disorders.</p>
<p>There are many methods to study our brain. Still, from the translational and non-invasive perspectives, the neuroimaging method is an ideal option. In this Research Topic, we included seven articles about the neuroimaging investigation of mood and anxiety disorders (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2020.577628">Ballard et al.</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2020.574819">Zhou et al.</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2020.600583">Zhang Y. et al.</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2021.623765">Zhang T. et al.</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2021.670739">Zhang J. et al.</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2021.670974">Per&#x000E4;kyl&#x000E4; et al.</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2021.659121">Oh et al.</ext-link>). Their neuroimaging methods included magnetoencephalography (MEG; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2020.577628">Ballard et al.</ext-link>), functional and structural magnetic resonance imaging (MRI; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2020.574819">Zhou et al.</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2020.600583">Zhang Y. et al.</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2021.670739">Zhang J. et al.</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2021.659121">Oh et al.</ext-link>), repetitive transcranial magnetic stimulation (r-TMS; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2021.623765">Zhang T. et al.</ext-link>), and electroconvulsive therapy (ECT; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2021.670974">Per&#x000E4;kyl&#x000E4; et al.</ext-link>). The mood and anxiety conditions discussed in the seven articles of this Research Topic consisted of suicide crisis (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2020.577628">Ballard et al.</ext-link>), bipolar II depression (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2020.574819">Zhou et al.</ext-link>), major depressive disorder (MDD; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2020.600583">Zhang Y. et al.</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2021.623765">Zhang T. et al.</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2021.670739">Zhang J. et al.</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2021.670974">Per&#x000E4;kyl&#x000E4; et al.</ext-link>), and obsessive-compulsive disorder (OCD; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2021.659121">Oh et al.</ext-link>). Four articles investigated depression-related brain alterations (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2020.577628">Ballard et al.</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2020.574819">Zhou et al.</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2020.600583">Zhang Y. et al.</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2021.670974">Per&#x000E4;kyl&#x000E4; et al.</ext-link>).</p>
<p>One work in this Research Topic found that the amygdala and insula connectivity alterations may play a role in implicit suicidal associations (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2020.577628">Ballard et al.</ext-link>). The connectivity estimates between the early visual cortex, anterior insula, and amygdala may identify the suicide crisis patients with acceptable sensitivity and specificity. Another work found the slow five fractional amplitude of low-frequency fluctuations associated with bipolar II depression symptoms in several clusters (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2020.574819">Zhou et al.</ext-link>). For MDD, one article found reductions of gray matter volume in the fronto-limbic-striatal regions, including the prefrontal lobe, limbic system, striatum, cerebellum, temporal lobe, and bilateral lingual gyri (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2020.600583">Zhang Y. et al.</ext-link>). A strength of that study is that it only included first-episode medicine-naive MDD patients.</p>
<p>Another article used rTMS with different frequency parameters in the dorsolateral prefrontal cortex within a randomized double-blinded controlled trial (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2021.623765">Zhang T. et al.</ext-link>). The study found no statistical differences in the efficacy of rTMS between unilateral left and bilateral DLPFC and between 5 and 10 Hz for treating MDD. The aim of another article was to find possible therapeutic effects for acupuncture in MDD (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2021.670739">Zhang J. et al.</ext-link>). It found that the potential effects might be limited to the functional MRI perspectives, such as increased functional connectivity of the anterior cingulate cortex. Conversely, it did not identify significant neurological changes in any DTI or VBM studies after acupuncture treatment in MDD. Yet another work about MDD in this topic used novel indices derived from threat modulation (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2021.670974">Per&#x000E4;kyl&#x000E4; et al.</ext-link>). The authors found that executive function and working memory indicators may be potential objective biomarkers of depression severity before ECT and cognitive outcome after ECT.</p>
<p>The only article not related to depression in this Research Topic focused on OCD. The researchers used a mental rotation task to assess whether activation in the right dorsolateral prefrontal cortex in patients with OCD was positively associated with clinical severity (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpsyt.2021.659121">Oh et al.</ext-link>). OCD patients could activate the frontoparietal regions like healthy controls during the task, but the results indicated the possible specific pattern of alterations of OCD patients.</p>
<p>With such rich content and broad coverage in the discussion of neuroimaging findings in MDD and OCD, we hope you have a great journey and harvest when you enjoy the exciting and meaningful results in the articles of this Research Topic.</p>
<sec id="s1">
<title>Author Contributions</title>
<p>C-HL drafted the manuscript. JR and Y-KK advised and revised the manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec>
<sec sec-type="disclaimer" id="s2">
<title>Publisher&#x00027;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec> </body>
</article>